Public signalCompany raiseAuto-indexed · Unverified
Stipple Bio, Inc. raised $65.1M
Stipple Bio, Inc.· Cambridge, US· Biotechnology· Filed Apr 6, 2026
Stipple Bio, Inc. reported raising capital. Based in Cambridge, MASSACHUSETTS, US. First sale reported 2026-03-31. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$65.1M
Confidence90%
On the record
- Location
- Cambridge, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $65.1M
- Target amount
- $100.2M
- Filing date
- Apr 6, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 65,130,013 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Apr 6, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Stipple Bio, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record